Yee Chung Cheng

Also affiliated with Froedtert Hospital, Medical College of Wisconsin

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy”.

Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-07038-3

N/A

0.545DataRank · unranked

10 citations

Julie M. Jorns, Yunguang Sun, Yee Chung Cheng, Sailaja Kamaraju, John Burfeind +16 more

Establishing an interdisciplinary research team for cardio-oncology artificial intelligence informatics precision and health equity

American Heart Journal Plus Cardiology Research and Practice(2022)10.1016/j.ahjo.2022.100094

N/A

0.524DataRank · unranked

32 citations

Rodney Sparapani, Kristen Osinski, Jun Zhang, Jeffrey Blessing, Feixiong Cheng +15 more

Team principles for successful interdisciplinary research teams

American Heart Journal Plus Cardiology Research and Practice(2023)10.1016/j.ahjo.2023.100306

N/A

0DataRank · unranked

47 citations

Rodney Sparapani, Kristen Osinski, Jun Zhang, Jeffrey Blessing, Feixiong Cheng +15 more

Frequent Upregulation Of HER2 Protein In Hormone Receptor-Positive HER2-Negative Breast Cancer After Short-Term Neoadjuvant Endocrine Therapy

Research Square(2023)10.21203/rs.3.rs-2777910/v1

N/A

0DataRank · unranked

2 citations

Julie M. Jorns, Yunguang Sun, Yee Chung Cheng, Sailaja Kamaraju, John Burfeind +16 more

Neoadjuvant HER2-targeted regimens with or without anthracyclines for HER2-positive inflammatory breast cancer: a multicenter retrospective study

Breast Cancer Research and Treatment(2025)10.1007/s10549-025-07795-3

N/A

0DataRank · unranked

0 citations

N Sridhar, Megumi Kai, Wenli Dong, Shen Yu, Savitri Krishnamurthy +14 more